Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes
Shugo Tohyama1, Jun Fujita2, Chihana Fujita2
1Department of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Department of Organ Fabrication, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Scaling up human induced pluripotent stem cell (hiPSC) culture is crucial for cardiac regeneration. This study introduces a multilayer culture system with active gas ventilation, enabling efficient large-scale production of hiPSC-derived cardiomyocytes for heart failure therapies.
Area of Science:
- Stem Cell Biology
- Cardiovascular Research
- Regenerative Medicine
Background:
- Large-scale culture of human induced pluripotent stem cells (hiPSCs) is a significant challenge for cardiac regenerative therapies.
- Existing methods often struggle with scalability and maintaining cell pluripotency during expansion.
Purpose of the Study:
- To develop and validate a scalable 2D culture system for human induced pluripotent stem cells (hiPSCs).
- To optimize the differentiation of hiPSCs into cardiomyocytes (CMs) using this novel culture system.
- To facilitate the clinical application of hiPSC-derived CMs for treating heart failure.
Main Methods:
- Utilized multilayer culture plates (CPs) with active gas ventilation (AGV) for hiPSC expansion.
- Cultured hiPSCs to achieve high cell densities while maintaining pluripotency.
- Employed a sequential 2D differentiation protocol to generate cardiomyocytes (CMs).
- Implemented metabolic purification techniques to isolate purified CMs.
Main Results:
- Achieved stable hiPSC proliferation and pluripotency in multilayer CPs with AGV.
- Successfully scaled hiPSC culture, yielding up to 1.7 x 10^9 cells in 10-layer CPs.
- Demonstrated high cardiac differentiation efficiency (66%-87%) using the 10-layer CPs with AGV.
- Obtained a massive amount of purified cardiomyocytes (1.5-2.8 x 10^9 cells) after metabolic purification.
Conclusions:
- A scalable 2D culture system using multilayer CPs with AGV effectively supports hiPSC expansion and differentiation into cardiomyocytes.
- This optimized culture and differentiation strategy significantly enhances the yield of hiPSC-derived CMs.
- The developed system holds promise for advancing clinical applications of cell-based therapies for severe heart failure.
More Related Videos
09:23Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
Published on: March 10, 2023
10:37Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
